GEODE CAPITAL MANAGEMENT, LLC - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,175,052
+33.7%
575,080
+9.4%
0.00%0.0%
Q2 2023$13,596,297
+35.3%
525,562
+25.7%
0.00%
+100.0%
Q1 2023$10,045,508
+128804.2%
418,214
+4.6%
0.00%0.0%
Q4 2022$7,793
-99.9%
399,682
+5.3%
0.00%0.0%
Q3 2022$7,973,000
+45.9%
379,502
+35.1%
0.00%0.0%
Q2 2022$5,465,000
+26.4%
280,860
+43.0%
0.00%0.0%
Q1 2022$4,325,000
+56.9%
196,438
+13.6%
0.00%
Q4 2021$2,757,000
-21.7%
172,893
-2.1%
0.00%
Q3 2021$3,519,000
+16.8%
176,673
+1.4%
0.00%
Q2 2021$3,013,000
-11.8%
174,271
+1.1%
0.00%
-100.0%
Q1 2021$3,417,000
+74.4%
172,430
+53.7%
0.00%
Q4 2020$1,959,000
-7.5%
112,212
+2.1%
0.00%
Q3 2020$2,118,000
+4.1%
109,927
+5.2%
0.00%
Q2 2020$2,034,000
+55.6%
104,540
+12.0%
0.00%
Q1 2020$1,307,000
-54.5%
93,358
-20.3%
0.00%
Q4 2019$2,872,000
+1261.1%
117,136
+456.3%
0.00%
Q3 2019$211,00021,0580.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,470,392$204,464,38713.58%
NEA Management Company, LLC 2,186,243$69,085,2795.34%
TANG CAPITAL MANAGEMENT LLC 1,137,107$35,932,5815.07%
BOONE CAPITAL MANAGEMENT LLC 389,791$12,317,3963.89%
Highlander Partners, L.P. 122,980$3,886,1683.84%
BVF INC/IL 4,370,024$138,092,7583.72%
Prosight Management, LP 353,508$11,170,8533.54%
Novo Holdings A/S 1,500,000$47,400,0003.50%
Nicholas Investment Partners, LP 1,199,366$37,899,9662.83%
Eventide Asset Management 3,958,579$125,091,0972.25%
View complete list of MIRUM PHARMACEUTICALS INC shareholders